Ethos Financial Group, LLC Lixte Biotechnology Holdings, Inc. Transaction History

Ethos Financial Group, LLC

  • $568 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$0.48 - $6.0 $119,080 - $1.49 Million
248,084 New
248,084 $126 Million

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33.6M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email